Oppenheimer analyst issues PERFORM recommendation for DRUG on August 20, 2026 03:27PM ET. DRUG was trading at $78.6742 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
Citigroup analyst issues BUY recommendation for MRT on August 20, 2026 01:10PM ET. The previous analyst recommendation was Buy.MRT was trading at $1.9563 at issue of the analyst recommendation.The overall...
Benchmark analyst issues BUY recommendation for ASST on August 20, 2026 01:16PM ET. The previous analyst recommendation was Buy.ASST was trading at $15.56 at issue of the analyst recommendation.The overall...
Benchmark analyst issues BUY recommendation for MRT on August 20, 2026 12:36PM ET. The previous analyst recommendation was Buy.MRT was trading at $1.96 at issue of the analyst recommendation.The overall...
H.C. Wainwright analyst issues BUY recommendation for DRUG on August 20, 2026 10:59AM ET. The previous analyst recommendation was Buy.DRUG was trading at $84.74 at issue of the analyst recommendation.The...
Benchmark analyst issues BUY recommendation for DRUG on August 20, 2026 10:59AM ET. The previous analyst recommendation was Buy.DRUG was trading at $84.74 at issue of the analyst recommendation.The overall...
Craig-Hallum analyst issues BUY recommendation for QNCX on August 20, 2026 11:20AM ET. QNCX was trading at $34.57 at issue of the analyst recommendation.The overall analyst consensus : HOLD.Current analyst...
BTIG analyst issues BUY recommendation for LNSR on August 20, 2026 11:55AM ET. The previous analyst recommendation was Buy.LNSR was trading at $8.72 at issue of the analyst recommendation.The overall...
William Blair analyst issues OUTPERFORM recommendation for SRZN on August 20, 2026 09:57AM ET. SRZN was trading at $24.01 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Guggenheim analyst issues BUY recommendation for CALC on August 20, 2026 06:34AM ET. CALC was trading at $0.6131 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst...
